AE Wealth Management LLC lifted its position in Danaher Co. (NYSE:DHR) by 24.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,133 shares of the conglomerate’s stock after purchasing an additional 1,018 shares during the period. AE Wealth Management LLC’s holdings in Danaher were worth $507,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Tower Research Capital LLC TRC acquired a new position in shares of Danaher during the second quarter worth $1,355,000. Marshall Wace LLP acquired a new position in shares of Danaher during the second quarter worth $945,000. Zacks Investment Management increased its position in shares of Danaher by 80.3% during the second quarter. Zacks Investment Management now owns 74,288 shares of the conglomerate’s stock worth $7,331,000 after purchasing an additional 33,094 shares in the last quarter. Signaturefd LLC increased its position in shares of Danaher by 13.8% during the second quarter. Signaturefd LLC now owns 5,294 shares of the conglomerate’s stock worth $522,000 after purchasing an additional 641 shares in the last quarter. Finally, Paloma Partners Management Co increased its position in shares of Danaher by 166.3% during the second quarter. Paloma Partners Management Co now owns 14,757 shares of the conglomerate’s stock worth $1,456,000 after purchasing an additional 9,215 shares in the last quarter. Hedge funds and other institutional investors own 76.95% of the company’s stock.
A number of equities analysts have recently issued reports on the company. Zacks Investment Research downgraded Danaher from a “hold” rating to a “sell” rating in a research report on Monday, July 16th. Royal Bank of Canada upped their price target on Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. ValuEngine downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Thursday, June 21st. Morgan Stanley upped their price target on Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, July 20th. Finally, Bank of America set a $113.00 price target on Danaher and gave the stock a “buy” rating in a research report on Thursday, July 19th. Two research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $109.20.
NYSE DHR opened at $106.87 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.07 and a current ratio of 1.50. Danaher Co. has a 1 year low of $83.81 and a 1 year high of $107.77. The firm has a market capitalization of $74.03 billion, a P/E ratio of 26.52, a PEG ratio of 2.02 and a beta of 1.03.
Danaher (NYSE:DHR) last released its earnings results on Thursday, July 19th. The conglomerate reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.06. Danaher had a return on equity of 11.55% and a net margin of 13.84%. The firm had revenue of $4.98 billion for the quarter, compared to the consensus estimate of $4.91 billion. During the same period in the prior year, the firm earned $0.99 EPS. The firm’s revenue was up 10.4% on a year-over-year basis. analysts expect that Danaher Co. will post 4.49 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.60%. The ex-dividend date is Thursday, September 27th. Danaher’s payout ratio is 15.88%.
In related news, CFO Daniel L. Comas sold 77,407 shares of the company’s stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $103.93, for a total value of $8,044,909.51. Following the transaction, the chief financial officer now directly owns 135,218 shares of the company’s stock, valued at approximately $14,053,206.74. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Mitchell P. Rales bought 1,080 shares of the business’s stock in a transaction that occurred on Tuesday, July 31st. The stock was purchased at an average cost of $102.32 per share, for a total transaction of $110,505.60. Following the completion of the transaction, the chairman now owns 1,827,953 shares in the company, valued at $187,036,150.96. The disclosure for this purchase can be found here. Over the last three months, insiders sold 299,961 shares of company stock worth $30,619,691. 11.90% of the stock is owned by insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: What is a closed-end mutual fund (CEF)?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.